Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice - Wikidata - awgldk - TriplyDB

Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice

Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice

http://www.wikidata.org/entity/Q28594067

about

Amyolid precursor protein mediates presynaptic localization and activity of the high-affinity choline transporter Choline transporter-like protein 4 (CTL4) links to non-neuronal acetylcholine synthesis Cholinergic activity as a new target in diseases of the heart Ablation of RIC8A function in mouse neurons leads to a severe neuromuscular phenotype and postnatal death Alzheimer's disease: Targeting the Cholinergic System Impaired Presynaptic High-Affinity Choline Transporter Causes a Congenital Myasthenic Syndrome with Episodic Apnea Ultrastructural localization of high-affinity choline transporter in the rat anteroventral thalamus and ventral tegmental area: differences in axon morphology and transporter distribution The vesicular acetylcholine transporter is required for neuromuscular development and function The Concise Guide to PHARMACOLOGY 2013/14: transporters.Transgenic overexpression of the presynaptic choline transporter elevates acetylcholine levels and augments motor endurance.Vagus nerve through α7 nAChR modulates lung infection and inflammation: models, cells, and signals Tachycardia, reduced vagal capacity, and age-dependent ventricular dysfunction arising from diminished expression of the presynaptic choline transporter.Functional neuromuscular junctions formed by embryonic stem cell-derived motor neurons.Defective presynaptic choline transport underlies hereditary motor neuropathy.Motor neuron-specific overexpression of the presynaptic choline transporter: impact on motor endurance and evoked muscle activity Gene-expression changes in cerium chloride-induced injury of mouse hippocampus.Drosophila melanogaster as a genetic model system to study neurotransmitter transporters.Identification and characterization of ML352: a novel, noncompetitive inhibitor of the presynaptic choline transporter.Sustained attention in mice: expanding the translational utility of the SAT by incorporating the Michigan Controlled Access Response Port (MICARP).Synthesis and structure-activity relationships of a series of 4-methoxy-3-(piperidin-4-yl)oxy benzamides as novel inhibitors of the presynaptic choline transporter.Prenatal choline deficiency increases choline transporter expression in the septum and hippocampus during postnatal development and in adulthood in rats Choline transport and de novo choline synthesis support acetylcholine biosynthesis in Caenorhabditis elegans cholinergic neurons.Discovery of Compounds that Positively Modulate the High Affinity Choline Transporter.Nonoisotopic assay for the presynaptic choline transporter reveals capacity for allosteric modulation of choline uptake.The "ins" and "outs" of the high-affinity choline transporter CHT1.Age-related attenuation of parasympathetic control of the heart in mice.Cognitive effects of dopamine depletion in the context of diminished acetylcholine signaling capacity in mice.Muscarinic receptor agonists and antagonists: effects on cancer The presynaptic choline transporter imposes limits on sustained cortical acetylcholine release and attention Cholinergic Targets in Lung Cancer Interpreting neonatal lethal phenotypes in mouse mutants: insights into gene function and human diseases.Monitoring cholinergic activity during attentional performance in mice heterozygous for the choline transporter: a model of cholinergic capacity limits.Vesicular and plasma membrane transporters for neurotransmitters.Choline transporter-like proteins CTLs/SLC44 family as a novel molecular target for cancer therapy.Hemicholinium-3 sensitive choline transport in human T lymphocytes: Evidence for use as a proxy for brain choline transporter (CHT) capacity.Unresponsive Choline Transporter as a Trait Neuromarker and a Causal Mediator of Bottom-Up Attentional Biases.Cholinergic genetics of visual attention: Human and mouse choline transporter capacity variants influence distractibility.Ubiquitin C-terminal hydrolase L1 interacts with choline transporter in cholinergic cells.Targeting Phospholipid Metabolism in Cancer.Detection of choline transporter-like 1 protein CTL1 in neuroblastoma x glioma cells and in the CNS, and its role in choline uptake.

P2860

2ea69d5866f7b364627df19f3dfe731ece6bbe02 3721e01a4d88fd99dd06fdb2cf59b95bd5fb01e2 4541fb9a31d0633e6055fe149428b23d8da80632 ac1fec1e2699243bf48e7a1b637225afbaaf4979 cafb50771f98835438e1b72f045e4ba2ac851bb3

P248

Q24337889-91DB8D74-5F3A-4C0B-80FF-6C61C9E13FD0 Q24339568-FCF79FEC-75F2-49EC-A4F7-55CC7D36EF57 Q27004543-F14CFA7A-0B79-4202-8222-5537EC58FC4C Q27307146-CAC508F9-C1E9-45BF-AD9E-C5DFEB4CE130 Q28070135-5B5BD03A-C527-475F-9831-B8B3AF823CB9 Q28115635-96D26873-2BE8-4AA4-9ACE-0222DBB9E9C5 Q28581795-A49BE6EF-CBCE-46A4-B30F-E12FCB26AA69 Q30436632-A5405EE6-8573-4C74-B22D-A2F27A420780 Q30486743-0B173CE3-E51E-4838-AFA8-40733B414AD5 Q33924266-9F8AC59B-153B-45A0-802C-63783D06542E Q34022416-47F5F059-7F2F-441D-A808-EEF94A1D4D57 Q34150552-555CBE15-7BE9-468C-B8E0-1FFF628641F6 Q34264572-F8F59117-65D8-43DA-AF6F-E0022FF8F594 Q34310899-1115D16B-AF7B-431F-85C0-1C78B4AB5E51 Q34355414-E23AAB10-250A-430B-9FFB-0A263082C001 Q34661863-99963ADA-C376-4545-BD8D-19BC96F3F99E Q34690868-5175E8A6-B72B-4CE0-A73A-56DCC22EF2DB Q35199186-C09596B3-B42E-4F5A-B78E-3552AB0C1359 Q35231692-9F69ED4D-D9DE-446C-B2C6-331E03616096 Q35269228-EFDD3D9A-0CEA-4D6F-8D57-7566A5A3D5A8 Q35951552-D6B4A98B-7ECB-40F2-9EE4-0DB5690F5E96 Q36052286-27CC2C9D-1320-47C2-981F-DBC41E9016DE Q36306913-C8F23120-666E-4274-A16E-11EC3E93F370 Q36326822-41A3F7F9-BA05-4AC3-8EDA-291DC68990F4 Q36416443-814D2E88-7E54-4168-AD62-418AC2CE5D4B Q36420103-9F56B96C-DC6D-4E3E-98F3-FEEF2B818C58 Q36486037-B15D60FD-A477-4183-A77D-F6BA24442D14 Q36706667-E9F5587B-5282-4490-A8CD-E9AF2F3E7965 Q37012325-A40F5ACF-113D-4A78-9EBA-91A513FCD0F0 Q37127226-DFA58BFF-4EE0-45A6-BAC2-E357871D770A Q37363610-029E9A65-7B15-468E-9190-B619EAB65090 Q37397067-EEA7A036-2EFD-490A-9082-B02492277558 Q37971367-83127F68-83E9-4DA9-8D2A-1EC04E57A21C Q38188522-40CE5C91-DD27-4D4D-87F6-07D3E6E24255 Q38430806-15D39DE6-D1F7-4C29-B8EA-79B8BE3E572B Q38433275-26974844-80A6-4A81-89ED-781BDEF62CD4 Q38893910-D85E095E-D2E4-4A3B-A160-21C2BC7B6ECA Q39024141-C43A119F-66A4-4161-A8E3-1266068823D2 Q39084885-2DE950F0-3C1C-4114-8812-63E801C4EA12 Q39839354-3D90B905-0409-4186-BD60-05A2055B7D20

P2860

Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice

http://www.wikidata.org/entity/Q28594067

description

2004 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունիսին հրատարակված գիտական հոդված

@hy

article publié dans les Procee ...... f the United States of America

@fr

artículu científicu espublizáu en 2004

@ast

im Juni 2004 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

vedecký článok (publikovaný 2004/06/08)

@sk

vědecký článek publikovaný v roce 2004

@cs

wetenschappelijk artikel (gepubliceerd op 2004/06/08)

@nl

наукова стаття, опублікована в червні 2004

@uk

name

Lethal impairment of cholinerg ...... line transporter knockout mice

@ast

Lethal impairment of cholinerg ...... line transporter knockout mice

@en

Lethal impairment of cholinerg ...... line transporter knockout mice

@nl

type

label

Lethal impairment of cholinerg ...... line transporter knockout mice

@ast

Lethal impairment of cholinerg ...... line transporter knockout mice

@en

Lethal impairment of cholinerg ...... line transporter knockout mice

@nl

prefLabel

Lethal impairment of cholinerg ...... line transporter knockout mice

@ast

Lethal impairment of cholinerg ...... line transporter knockout mice

@en

Lethal impairment of cholinerg ...... line transporter knockout mice

@nl

P1433

Q28594067-2EBC3B24-615C-4027-89C6-F832F31B0C02

P1476

Q28594067-C64979F8-5BFA-44AD-B064-8929B8471629

P2093

Q28594067-4014195F-51E8-482C-94ED-8B717B9F9940

Q28594067-4D93E7A1-4E04-4448-913A-34869278A0C8

Q28594067-B13908ED-D706-45E2-9A27-B4A49D9EAC29

Q28594067-BE6DA364-4298-4A3C-947B-766CA0DB752E

Q28594067-C5B83789-0FB2-467E-B47B-30620CEBABE7

Q28594067-DB20D437-FF3F-468B-AED6-F08F715DA07C

P2860

Q28594067-04561C6F-B7E4-4894-9F8B-745D4E737ECA

Q28594067-04963B41-0FBC-49BC-8CFC-1A6A51AA377B

Q28594067-04DAB5FF-6D3F-450B-84A8-ED89A841DBE2

Q28594067-074D70F8-90B0-484D-B118-3E30F8C8EDDA

Q28594067-0CCC42CA-DEF8-4BD1-9F32-12B4BD43A985

Q28594067-0D4C20F1-C25D-407E-B818-AD3F69B2246A

Q28594067-0E469310-B98C-4CC5-8E1B-3A967CEE99D1

Q28594067-106DD406-70BE-449C-8F9C-F89AA4BCF4D1

Q28594067-12508C1F-79DA-4187-AF79-AE8FF659F168

Q28594067-19CCC5DF-437C-457F-86C8-8E7421DECFF4

P304

Q28594067-7B0361B5-355B-47E9-B8A7-F621ECFF9D2F

P31

Q28594067-83DE5E38-011D-45F4-BDBC-7BE1125226FE

P356

Q28594067-9410FCE7-0F52-4CCB-8F02-6715E72C06FB

P407

Q28594067-E29E475D-2FC7-40D1-9C00-6F5E655B5094

P433

Q28594067-BE25589D-F3D6-4BBC-808D-154BBAE7A185

P478

Q28594067-C8F025BA-B188-481A-ADBF-84F115FFBF47

P577

Q28594067-5A8EB5A9-6C34-487E-B5B9-F2D5DDEF0914

P5875

Q28594067-250A210E-0EC6-4144-ACA0-28244D38FDF4

P698

Q28594067-B0296478-C2F0-4B38-B58B-3E4FE7C0C568

P921

Q28594067-C5D82E9C-747C-4173-AC59-A385971455DC

Q28594067-E8C3563B-8749-4E42-A680-071A3DDAD2F2

P932

Q28594067-9A8ED9AE-CFE0-4FAA-B3FE-2873FA00025F

P356

PNAS.0401667101

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Lethal impairment of cholinerg ...... line transporter knockout mice

@en

P2093

Jane Wright

http://www.w3.org/2001/XMLSchema#string

Juan Carlos Tapia

http://www.w3.org/2001/XMLSchema#string

Mihaela Bazalakova

http://www.w3.org/2001/XMLSchema#string

Randy D. Blakely

http://www.w3.org/2001/XMLSchema#string

Shawn M. Ferguson

http://www.w3.org/2001/XMLSchema#string

Valentina Savchenko

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of a human, hemicholinium-3-sensitive choline transporter

Single nucleotide polymorphism of the human high affinity choline transporter alters transport rate

Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans

Development of the vertebrate neuromuscular junction

Aberrant patterning of neuromuscular synapses in choline acetyltransferase-deficient mice

Roles of neurotransmitter in synapse formation: development of neuromuscular junctions lacking choline acetyltransferase

Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice

Identification and characterization of the high-affinity choline transporter

Overview of nicotinic receptors and their roles in the central nervous system.

Choline acetyltransferase mutations in myasthenic syndrome due to deficient acetylcholine resynthesis.

P304

8762–8767

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0401667101

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8532420

http://www.w3.org/2001/XMLSchema#string

P698

15173594

http://www.w3.org/2001/XMLSchema#string

P921

Solute carrier family 5 (choline transporter), member 7

P932

423269

http://www.w3.org/2001/XMLSchema#string